BioCryst Receives European Commission Approval of ORLADEYO™ (berotralstat), First Oral, Once-daily Therapy to Prevent Attacks in Hereditary Angioedema Patients
RESEARCH TRIANGLE PARK, N.C., April 30, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX)…
UAE-Based The Black Box Announces Project Pipeline Exceeding USD 10 Million Following Participation at Make it in the Emirates 2026
Lerner & Rowe Gives Back to Host 5th Annual Cornhole Tournament on May 9 in Crown Point, Indiana
Sagtec Global Limited Strengthens Smart Property Development Collaboration Following Stateight Sdn Bhd’s Industry Recognition
TruMerit and Credivera Issue First Verifiable Digital Credentials for Global Healthcare Professionals
MK International Achieves ASEAN & Asia Records for Proprietary Quantum Molecular Technology Spray Series